Research Antibodies and Reagents Market by Product (Reagents and Research Antibodies), by Technology (Western Blotting, Immunofluorescence, Immunosorbent Assays, Flow Cytometry, Immunohistochemistry, and Immunoprecipitation), by Application (Proteomics, Drug Discovery & Development, and Genomics), and by End User (Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, and Contract Research Organizations)- Global Opportunity Analysis and Industry Forecasts To 2023.

Research antibodies and reagents are used concurrently during an experimental research for the development of protein, gene, or antigen specific drugs and biomarkers for rapid detection and diagnosis of chronic diseases. Global research antibodies and reagents market is expected to reach USD 13,276.5 million by 2023, at a CAGR of 6.5% during the forecast period of 2018 to 2023.

Succeeding an extensive secondary and primary research on research antibodies & reagents and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market dynamics segment. Rising proteomics and genomics research studies, increasing funding for research activities, and growing industry-academia collaborations are majorly driving the global research antibodies and reagents market. However, high cost and time related to development of potential antibodies hinders the growth of this market to some extent.

In addition, the report further gives an extensive outlook on various healthcare facilities served by the research antibodies and reagents. These industries include pharmaceutical and biotechnology industry, academic and research institutes, and contract research organizations. These end user segments further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use of research antibodies and reagents in these verticals to improve overall efficiency and outcomes of the research experiments for drug discovery and development.

An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017).

The key players in the global research antibodies and reagents market are GE Healthcare (U.S.), Merck & Co., Inc.(U.S.), Thermo Fisher Scientific Inc.(U.S.), Amgen Inc.(U.S.), Sanofi (France), F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc.(U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc.(U.S.), Eli Lilly and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc.(U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc.(U.S.), BioLegend, Inc.(U.S.), Abcam PLC (U.K.), and Cell Signaling Technology, Inc.(U.S.).

Scope of the report
Market by Product:

  • Reagents
  • ·Media and Serum
  • ·Stains and Dyes
  • ·Probes
  • ·Buffers
  • ·Solvents
  • ·Enzymes
  • ·Proteins
  • ·Others
  • Research Antibodies
  • ·Research Antibodies Market, by Type

  • Primary Antibodies
  • Secondary Antibodies
  • ·ResearchAntibodies Market, by Production
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Antibodies Fragments
  • ·Research Antibodies Market, by Source
  • Mouse
  • Rabbit
  • Others
  • ·Research Antibodies Market, by Research Areas

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Immunology
  • Neurology
  • Stem Cell
  • Others

Market by Technology:

  • ·Western Blotting
  • ·Immunofluorescence
  • ·Immunosorbent Assays
  • ·Flow Cytometry
  • ·Immunohistochemistry
  • ·Immunoprecipitation
  • ·Others

Market by Application:

  • ·Proteomics
  • ·Drug Discovery & Development
  • ·Genomics

Market by End User:

  • ·Pharmaceutical and Biotechnology Industry
  • ·Academic and Research Institutes
  • ·Contract Research Organizations

Market by Geography

  • North America
  • ·U.S.

  • ·Canada
  • Europe
  • ·Germany
  • ·France
  • ·U.K.

  • ·Italy
  • ·Spain
  • ·Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • ·Japan
  • ·China
  • ·India
  • ·Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa